LouisianaLouisiana’s rare cancer board meets publicly and reports to lawmakers
Louisiana’s rare cancer advisory board includes four specialized doctors and sends reports to lawmakers after its meetings.
What it does
Four doctors who specialize in rare cancer treatments serve on the advisory board alongside state officials and medical and research representatives.
The board holds public meetings every three months, unless its members vote for a different schedule or the chair orders one. It reports its findings to both insurance committees within 45 days after each meeting.
Argument forWritten reports after board meetings could help lawmakers follow the board’s findings on rare cancer treatments.
Argument againstThe board’s vote or chair could change the quarterly meeting schedule, making it harder for the public to predict when it can attend.
More detail
The board has four oncologists who specialize in rare cancer treatments. The board also includes state health and insurance officials, medical and research representatives, and other members listed in the law.
The board holds public meetings every three months and sends a written report of its findings to the House and Senate insurance committees after each meeting. The reports go to the House Committee on Insurance and the Senate Committee on Insurance. The board may set a different meeting schedule by vote, or the chair may order one. The report is due no later than 45 days after each meeting.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jun 8Signed by the Governor Jeff Landry. Becomes Act No. 832.Became Law
- Jun 8Effective date: 06/08/2026.
- Jun 1Signed by the President of the Senate.
- Jun 1Sent to the Governor for executive approval.To Governor
- May 31Enrolled and signed by the Speaker of the House.Minor
- May 29Scheduled for concurrence on 05/29/2026.
- Vote recorded CONCUR IN SENATE AMENDMENTS (#1737). Result: pass.Lower
- May 29Read by title, roll called, yeas 100, nays 0, Senate amendments concurred in.
- May 28The amended bill was read by title, passed by a vote of 34 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.Passed Senate
- Vote recorded FINAL PASSAGE (#1497). Result: pass.Upper
- May 28Received from the Senate with amendments.Minor
- May 27Rules suspended. Reported with amendments. Rules suspended. Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.Minor
- May 27Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.Minor
- Apr 20Read second time by title and referred to the Committee on Insurance.Minor
- Apr 15Received in the Senate. Read first time by title and placed on the Calendar for a second reading.Minor
- Apr 14Read third time by title, amended, roll called on final passage, yeas 98, nays 0. Finally passed, title adopted, ordered to the Senate.Passed House
- Vote recorded FINAL PASSAGE (#490). Result: pass.Lower
- Apr 13Scheduled for floor debate on 04/14/2026.
- Apr 9Read by title, ordered engrossed, passed to 3rd reading.Minor
- Apr 8Reported favorably (12-0).Minor
- Mar 9Read by title, under the rules, referred to the Committee on Insurance.Minor
- Feb 27Prefiled.Minor
- Feb 27Under the rules, provisionally referred to the Committee on Insurance.Minor
- Feb 27First appeared in the Interim Calendar on 2/27/2026.Introduced
Healthcare